Apollo Hospitals Bannerghatta
Bangalore,India
Triple-negative breast cancer is characterized by the absence of progesterone receptors, estrogen receptors, and excess HER2 protein. Almost 10 to 20 percent of all breast cancer cases are triple-negative breast cancers. This means that the growth of the cancer cells in the breast is not fuelled by the estrogen or progesterone hormone or the HER2 proteins. This finding is important to know if hormonal therapy would be effective in the treatment for triple-negative breast cancer but not hormone therapy.
The signs and symptoms of triple-negative breast cancer are often the same as those of other subtypes, including the following:
If the triple-negative breast cancer spreads to other parts of the body, it shows similar metastatic breast cancer symptoms like any other subtype, which may include the following:
Here are some facts about triple-negative breast cancer that are alarming:
Recurrence or relapse is the return of breast cancer that can be local in the breast or in scar tissue or distally in other parts of the body. Distantly spread cancer is termed as metastatic cancer and is difficult to stop or treat.
Even though there are many treatment options available for triple-negative breast cancer, still the fear for recurrence is more than any other breast cancer as it is a more aggressive form. Its possibility of recurrence is greater in the first five years than other forms of the disease. However, it drops down sharply after five years.
It is quite upsetting and scary to know that you have triple-negative breast cancer, which is a more aggressive form and is not even a candidate for target hormone therapy. But it is also important to remember that there are other triple-negative breast cancer treatment options available that can manage it. It can be treated with a combination of surgery, radiation therapy, and chemotherapy. Most importantly, triple-negative breast cancer has a much better response to conventional chemotherapy than other breast cancer subtypes.
Also, neoadjuvant chemotherapy, that is chemotherapy before surgery, has been found to be very effective with complete pathologic response and disease-free survival. The overall survival is also better for neoadjuvant chemotherapy in triple-negative breast cancer.
One more category of drugs called PARP inhibitors is approved for the treatment of advanced-stage HER2-negative breast cancer in patients who have a BRCA1 or BRCA2 mutation.
In addition to these, research has proven that immunotherapy drug (Tecentriq), that boosts the immune system to work harder or smarter to attack cancer cells, along with chemotherapy can improve outcomes in advanced-stage triple-negative breast cancer.
So there are numerous treatment options available even for triple-negative breast cancer but no long post-therapy regimens. Though there is a fear for recurrence, there is a hidden benefit too. The treatment course is short as compared to another early-stage, slow-growing breast cancers whose treatment last for 10 years or more.
Triple-negative breast cancer is a higher grade cancer, grows very rapidly, and tends to metastasize. It has been observed that the five-year survival rate of this cancer is lower than other breast cancer types. According to BreastCancer.org, the five-year survival rate for other subtypes of breast cancer is 93 percent while the 5-year survival rate for triple-negative breast cancer is around 77 percent.
This means that in the case of cancer recurrence, there’s a higher risk of death. Although the survival of a cancer patient depends upon various factors such as the stage and grade of cancer as well as the response to treatment but still triple-negative breast cancer has a lower chance of survival if recurred.
Triple-negative breast cancer also has a high recurrence rate and recurrence is specifically greatest within the first three years. But after 5 years, the recurrence rate drops down sharply. This means that if a patient is disease-free for 5 years after treatment of triple-negative breast cancer, there are higher chances that cancer won’t reoccur later. But the follow-up is very important in every case.
Bangalore,India
First of its kind in South India, Apollo hospital in Bangalore is a delineated name among the Apollo chain of Hospitals. It is proud to have the state of the art armamentarium equipped with the right technologies under a single roof. After undergoing an extensive process of assessments the medical experts and doctors have been selected who have undergone trainings in international medical bodies around the world.
Apollo hospital Bangalore review shows that 99.6% is their success rate... Read More
111
PROCEDURES
38
DOCTORS in 13 Specialties
6+
Facilities & Amenities
Dubai,United Arab Emirates
2 Reviews
In the year 1992 with the noble vision of Dr. Zulekha Daud who shifted her base from India to Sharjah in order to serve people who are in need at an affordable cost, Zulekha Healthcare Group was established. She later established a hospital in Dubai too and Zulekha Dubai is now true to its mission of serving the suffering and the ailing. It is a multidisciplinary hospital with advanced diagnostic centers and well-equipped pharmacies. In the year 2004, the Dubai hospital saw its inception. It... Read More
100
PROCEDURES
13
DOCTORS in 10 Specialties
6+
Facilities & Amenities
2+
Reviews
Bangalore,India
Among hospitals in Bangalore one of the leading healthcare delivery providers is Fortis Bangalore. It has secured number 2 position in terms of being equipped with the latest technology and being one of the most advanced hospitals in the world. Their 24x7 emergency services and pharmacy services enfold their customers with a sense of security that the duty of health care is now in trusted hands. Not only some of the best doctors and surgeons man the hospital but there are numerous talented v... Read More
138
PROCEDURES
32
DOCTORS in 12 Specialties
20+
Facilities & Amenities
Sharjah,United Arab Emirates
In the year 1992 with the noble vision of Dr Zulekha Daud who shifted her base from India to Sharjah in order to serve people who are in need at an affordable cost, Zulekha Healthcare Group was established. She later established a hospital in Dubai too and Zulekha Dubai is now true to its mission of serving the suffering and the ailing. It is a multidisciplinary hospital with advanced diagnostic centres and well-equipped pharmacies. In the year 2004 the Dubai hospital saw its inception. It h... Read More
103
PROCEDURES
11
DOCTORS in 10 Specialties
6+
Facilities & Amenities
Bangalore,India
The future of cancer care has been revolutionized by HCG Bangalore. They have a team of best oncologist in Bangalore working with them thus bringing cancer care to a new step and dimensions. It started its operations as Bangalore Institute of Oncology which was started by a group of compassionate oncologists. They were the pioneers in terms of introducing many cutting edge technologies. Advanced diagnosis helps in proper selection of mode of treatments for various stages of cancer. The... Read More
27
PROCEDURES
8
DOCTORS in 3 Specialties
4+
Facilities & Amenities
Patients with triple-negative breast cancer should not lose hope and stay on the road to positivity by focusing on things like healthy eating, regular exercise, mindful meditation to cope stress, and periodic tests and regular medical follow-up with cancer specialists.
Also, as chemotherapy causes many cognitive difficulties, occupational therapy should be chosen to learn strategies to cope with all the cognitive deficits.
Psychosocial oncology team can provide support to cope with both bodily and mental depression. Support from friends, family, and neighbors also play a crucial role in giving strength to the patient to fight this deadly disease.
All in all, it is very important to work on mindfulness and live in the present moment, rather than dwelling on the past or fearing the future recurrence of cancer.
https://www.lbbc.org/learn/types-breast-cancer/triple-negative-breast-cancer/living-triple-negative-breast-cancer/risks
https://www.cbcn.ca/en/blog/our-stories/Kelina-tnbc-story
https://www.healthline.com/health/triple-negative-breast-cancer-recurrence
Guneet Bhatia is an avid reader, healthcare writer, and is currently Director of Patient Care Department, MediGence. She has also been featured on many prominent Healthcare portals such as IBTimes, HCIT Expert, Clinician Today.
(+1) 424 283 4838